APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 1 (IL1)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Interleukin 1 (IL1) Market Analysis and Forecast 2026-2032

19 December 2025204 pages

Choose your research edition.

Industry ResearchInterleukin 1 (IL1) Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 1 (IL1) Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Interleukin 1 (IL1) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 1 (IL1) Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 1 (IL1) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Interleukin 1 (IL1) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interleukin 1 (IL1) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Interleukin 1 (IL1) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Interleukin 1 (IL1) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Interleukin 1 (IL1) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Interleukin 1 (IL1) include Novartis AG, AbbVie Inc, XBiotech Inc, TWi Biotechnology Inc, Swedish Orphan Biovitrum AB, Regeneron Pharmaceuticals Inc, R Pharm, Peptinov SAS and Orphit SAS, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Interleukin 1 (IL1), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Interleukin 1 (IL1), also provides the sales of main regions and countries. Of the upcoming market potential for Interleukin 1 (IL1), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Interleukin 1 (IL1) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Interleukin 1 (IL1) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Interleukin 1 (IL1) sales, projected growth trends, production technology, application and end-user industry.

Interleukin 1 (IL1) Segment by Company

Novartis AG

AbbVie Inc

XBiotech Inc

TWi Biotechnology Inc

Swedish Orphan Biovitrum AB

Regeneron Pharmaceuticals Inc

R Pharm

Peptinov SAS

Orphit SAS

Optimum Therapeutics LLC

Opsona Therapeutics Ltd

Omnitura Therapeutics Inc

Immune Response BioPharma Inc

Exicure Inc

Cell Medica Ltd

Apexigen Inc

Anacor Pharmaceuticals Inc

Interleukin 1 (IL1) Segment by Type

APX-002

Diacerein CR

Canakinumab

IR-1000

Others

Interleukin 1 (IL1) Segment by Application

Fallopian Tube Cancer

Esophageal Cancer

Bechcer Disease

Bladder Cancer

Others

Interleukin 1 (IL1) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 1 (IL1) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 1 (IL1) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 1 (IL1).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Interleukin 1 (IL1) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Interleukin 1 (IL1) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interleukin 1 (IL1) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Interleukin 1 (IL1) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. APX-002 Major Manufacturers Table 3. Diacerein CR Major Manufacturers Table 4. Canakinumab Major Manufacturers Table 5. IR-1000 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Interleukin 1 (IL1) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Fallopian Tube Cancer Major Manufacturers Table 9. Esophageal Cancer Major Manufacturers Table 10. Bechcer Disease Major Manufacturers Table 11. Bladder Cancer Major Manufacturers Table 12. Others Major Manufacturers Table 13. Interleukin 1 (IL1) Industry Trends Table 14. Interleukin 1 (IL1) Industry Drivers Table 15. Interleukin 1 (IL1) Industry Opportunities and Challenges Table 16. Interleukin 1 (IL1) Industry Restraints Table 17. Global Interleukin 1 (IL1) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Interleukin 1 (IL1) Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Interleukin 1 (IL1) Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Interleukin 1 (IL1) Revenue Market Share by Region (2021-2026) Table 21. Global Interleukin 1 (IL1) Revenue Market Share by Region (2027-2032) Table 22. Global Interleukin 1 (IL1) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Interleukin 1 (IL1) Sales by Region (2021-2026) & (K Units) Table 24. Global Interleukin 1 (IL1) Sales by Region (2027-2032) & (K Units) Table 25. Global Interleukin 1 (IL1) Sales Market Share by Region (2021-2026) Table 26. Global Interleukin 1 (IL1) Sales Market Share by Region (2027-2032) Table 27. Global Interleukin 1 (IL1) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Interleukin 1 (IL1) Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Interleukin 1 (IL1) Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Interleukin 1 (IL1) Sales Market Share by Manufacturers (2021-2026) Table 31. Global Interleukin 1 (IL1) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Interleukin 1 (IL1) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Interleukin 1 (IL1) Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Interleukin 1 (IL1) Manufacturers, Product Type & Application Table 35. Global Interleukin 1 (IL1) Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Interleukin 1 (IL1) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Interleukin 1 (IL1) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Interleukin 1 (IL1) Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Interleukin 1 (IL1) Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Interleukin 1 (IL1) Revenue Market Share by Type (2021-2026) Table 42. Global Interleukin 1 (IL1) Revenue Market Share by Type (2027-2032) Table 43. Global Interleukin 1 (IL1) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 45. Global Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 46. Global Interleukin 1 (IL1) Sales Market Share by Type (2021-2026) Table 47. Global Interleukin 1 (IL1) Sales Market Share by Type (2027-2032) Table 48. Global Interleukin 1 (IL1) Price by Type (2021-2026) & (US$/Unit) Table 49. Global Interleukin 1 (IL1) Price by Type (2027-2032) & (US$/Unit) Table 50. Global Interleukin 1 (IL1) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Interleukin 1 (IL1) Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Interleukin 1 (IL1) Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Interleukin 1 (IL1) Revenue Market Share by Application (2021-2026) Table 54. Global Interleukin 1 (IL1) Revenue Market Share by Application (2027-2032) Table 55. Global Interleukin 1 (IL1) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 57. Global Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 58. Global Interleukin 1 (IL1) Sales Market Share by Application (2021-2026) Table 59. Global Interleukin 1 (IL1) Sales Market Share by Application (2027-2032) Table 60. Global Interleukin 1 (IL1) Price by Application (2021-2026) & (US$/Unit) Table 61. Global Interleukin 1 (IL1) Price by Application (2027-2032) & (US$/Unit) Table 62. Novartis AG Company Information Table 63. Novartis AG Business Overview Table 64. Novartis AG Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novartis AG Interleukin 1 (IL1) Product Portfolio Table 66. Novartis AG Recent Development Table 67. AbbVie Inc Company Information Table 68. AbbVie Inc Business Overview Table 69. AbbVie Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. AbbVie Inc Interleukin 1 (IL1) Product Portfolio Table 71. AbbVie Inc Recent Development Table 72. XBiotech Inc Company Information Table 73. XBiotech Inc Business Overview Table 74. XBiotech Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. XBiotech Inc Interleukin 1 (IL1) Product Portfolio Table 76. XBiotech Inc Recent Development Table 77. TWi Biotechnology Inc Company Information Table 78. TWi Biotechnology Inc Business Overview Table 79. TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. TWi Biotechnology Inc Interleukin 1 (IL1) Product Portfolio Table 81. TWi Biotechnology Inc Recent Development Table 82. Swedish Orphan Biovitrum AB Company Information Table 83. Swedish Orphan Biovitrum AB Business Overview Table 84. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Portfolio Table 86. Swedish Orphan Biovitrum AB Recent Development Table 87. Regeneron Pharmaceuticals Inc Company Information Table 88. Regeneron Pharmaceuticals Inc Business Overview Table 89. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio Table 91. Regeneron Pharmaceuticals Inc Recent Development Table 92. R Pharm Company Information Table 93. R Pharm Business Overview Table 94. R Pharm Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. R Pharm Interleukin 1 (IL1) Product Portfolio Table 96. R Pharm Recent Development Table 97. Peptinov SAS Company Information Table 98. Peptinov SAS Business Overview Table 99. Peptinov SAS Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Peptinov SAS Interleukin 1 (IL1) Product Portfolio Table 101. Peptinov SAS Recent Development Table 102. Orphit SAS Company Information Table 103. Orphit SAS Business Overview Table 104. Orphit SAS Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Orphit SAS Interleukin 1 (IL1) Product Portfolio Table 106. Orphit SAS Recent Development Table 107. Optimum Therapeutics LLC Company Information Table 108. Optimum Therapeutics LLC Business Overview Table 109. Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Optimum Therapeutics LLC Interleukin 1 (IL1) Product Portfolio Table 111. Optimum Therapeutics LLC Recent Development Table 112. Opsona Therapeutics Ltd Company Information Table 113. Opsona Therapeutics Ltd Business Overview Table 114. Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Portfolio Table 116. Opsona Therapeutics Ltd Recent Development Table 117. Omnitura Therapeutics Inc Company Information Table 118. Omnitura Therapeutics Inc Business Overview Table 119. Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Portfolio Table 121. Omnitura Therapeutics Inc Recent Development Table 122. Immune Response BioPharma Inc Company Information Table 123. Immune Response BioPharma Inc Business Overview Table 124. Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Immune Response BioPharma Inc Interleukin 1 (IL1) Product Portfolio Table 126. Immune Response BioPharma Inc Recent Development Table 127. Exicure Inc Company Information Table 128. Exicure Inc Business Overview Table 129. Exicure Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Exicure Inc Interleukin 1 (IL1) Product Portfolio Table 131. Exicure Inc Recent Development Table 132. Cell Medica Ltd Company Information Table 133. Cell Medica Ltd Business Overview Table 134. Cell Medica Ltd Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Cell Medica Ltd Interleukin 1 (IL1) Product Portfolio Table 136. Cell Medica Ltd Recent Development Table 137. Apexigen Inc Company Information Table 138. Apexigen Inc Business Overview Table 139. Apexigen Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Apexigen Inc Interleukin 1 (IL1) Product Portfolio Table 141. Apexigen Inc Recent Development Table 142. Anacor Pharmaceuticals Inc Company Information Table 143. Anacor Pharmaceuticals Inc Business Overview Table 144. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio Table 146. Anacor Pharmaceuticals Inc Recent Development Table 147. North America Interleukin 1 (IL1) Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Interleukin 1 (IL1) Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 150. North America Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 151. North America Interleukin 1 (IL1) Sales Price by Type (2021-2026) & (US$/Unit) Table 152. North America Interleukin 1 (IL1) Sales Price by Type (2027-2032) & (US$/Unit) Table 153. North America Interleukin 1 (IL1) Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Interleukin 1 (IL1) Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 156. North America Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 157. North America Interleukin 1 (IL1) Sales Price by Application (2021-2026) & (US$/Unit) Table 158. North America Interleukin 1 (IL1) Sales Price by Application (2027-2032) & (US$/Unit) Table 159. North America Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Interleukin 1 (IL1) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Interleukin 1 (IL1) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. North America Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 164. North America Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 165. North America Interleukin 1 (IL1) Sales Price by Country (2021-2026) & (US$/Unit) Table 166. North America Interleukin 1 (IL1) Sales Price by Country (2027-2032) & (US$/Unit) Table 167. United States Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 168. Canada Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 169. Europe Interleukin 1 (IL1) Revenue by Type (2021-2026) & (US$ Million) Table 170. Europe Interleukin 1 (IL1) Revenue by Type (2027-2032) & (US$ Million) Table 171. Europe Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 172. Europe Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 173. Europe Interleukin 1 (IL1) Sales Price by Type (2021-2026) & (US$/Unit) Table 174. Europe Interleukin 1 (IL1) Sales Price by Type (2027-2032) & (US$/Unit) Table 175. Europe Interleukin 1 (IL1) Revenue by Application (2021-2026) & (US$ Million) Table 176. Europe Interleukin 1 (IL1) Revenue by Application (2027-2032) & (US$ Million) Table 177. Europe Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 178. Europe Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 179. Europe Interleukin 1 (IL1) Sales Price by Application (2021-2026) & (US$/Unit) Table 180. Europe Interleukin 1 (IL1) Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Europe Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Europe Interleukin 1 (IL1) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Europe Interleukin 1 (IL1) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Europe Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. Europe Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 186. Europe Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 187. Europe Interleukin 1 (IL1) Sales Price by Country (2021-2026) & (US$/Unit) Table 188. Europe Interleukin 1 (IL1) Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Germany Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 190. France Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 191. U.K. Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 192. Italy Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 193. Netherlands Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 194. China Interleukin 1 (IL1) Revenue by Type (2021-2026) & (US$ Million) Table 195. China Interleukin 1 (IL1) Revenue by Type (2027-2032) & (US$ Million) Table 196. China Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 197. China Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 198. China Interleukin 1 (IL1) Sales Price by Type (2021-2026) & (US$/Unit) Table 199. China Interleukin 1 (IL1) Sales Price by Type (2027-2032) & (US$/Unit) Table 200. China Interleukin 1 (IL1) Revenue by Application (2021-2026) & (US$ Million) Table 201. China Interleukin 1 (IL1) Revenue by Application (2027-2032) & (US$ Million) Table 202. China Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 203. China Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 204. China Interleukin 1 (IL1) Sales Price by Application (2021-2026) & (US$/Unit) Table 205. China Interleukin 1 (IL1) Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Interleukin 1 (IL1) Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Interleukin 1 (IL1) Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 209. Asia Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 210. Asia Interleukin 1 (IL1) Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Asia Interleukin 1 (IL1) Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Asia Interleukin 1 (IL1) Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Interleukin 1 (IL1) Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 215. Asia Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 216. Asia Interleukin 1 (IL1) Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Asia Interleukin 1 (IL1) Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Interleukin 1 (IL1) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Interleukin 1 (IL1) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. Asia Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 223. Asia Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 224. Asia Interleukin 1 (IL1) Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Asia Interleukin 1 (IL1) Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Japan Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 227. South Korea Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 228. India Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 229. Australia Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 230. China Taiwan Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Interleukin 1 (IL1) Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Interleukin 1 (IL1) Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 235. SAMEA Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 236. SAMEA Interleukin 1 (IL1) Sales Price by Type (2021-2026) & (US$/Unit) Table 237. SAMEA Interleukin 1 (IL1) Sales Price by Type (2027-2032) & (US$/Unit) Table 238. SAMEA Interleukin 1 (IL1) Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Interleukin 1 (IL1) Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 241. SAMEA Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 242. SAMEA Interleukin 1 (IL1) Sales Price by Application (2021-2026) & (US$/Unit) Table 243. SAMEA Interleukin 1 (IL1) Sales Price by Application (2027-2032) & (US$/Unit) Table 244. SAMEA Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Interleukin 1 (IL1) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Interleukin 1 (IL1) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. SAMEA Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 249. SAMEA Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 250. SAMEA Interleukin 1 (IL1) Sales Price by Country (2021-2026) & (US$/Unit) Table 251. SAMEA Interleukin 1 (IL1) Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Brazil Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 253. Argentina Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 254. Chile Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 255. Colombia Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 256. Peru Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 258. Israel Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 259. UAE Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 260. Turkey Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 261. Iran Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 262. Egypt Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Interleukin 1 (IL1) Distributors List Table 266. Interleukin 1 (IL1) Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Interleukin 1 (IL1) Image Figure 2. Global Interleukin 1 (IL1) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 1 (IL1) Market Size Share 2021 VS 2025 VS 2032 Figure 4. APX-002 Image Figure 5. Diacerein CR Image Figure 6. Canakinumab Image Figure 7. IR-1000 Image Figure 8. Others Image Figure 9. Global Interleukin 1 (IL1) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Interleukin 1 (IL1) Market Size Share 2021 VS 2025 VS 2032 Figure 11. Fallopian Tube Cancer Image Figure 12. Esophageal Cancer Image Figure 13. Bechcer Disease Image Figure 14. Bladder Cancer Image Figure 15. Others Image Figure 16. Global Interleukin 1 (IL1) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Figure 18. Global Interleukin 1 (IL1) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Interleukin 1 (IL1) Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Interleukin 1 (IL1) Revenue Market Share by Region (2021-2032) Figure 21. Global Interleukin 1 (IL1) Sales (2021-2032) & (K Units) Figure 22. Global Interleukin 1 (IL1) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Interleukin 1 (IL1) Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Interleukin 1 (IL1) Sales YoY (2021-2032) & (K Units) Figure 25. Europe Interleukin 1 (IL1) Sales YoY (2021-2032) & (K Units) Figure 26. China Interleukin 1 (IL1) Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Interleukin 1 (IL1) Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Interleukin 1 (IL1) Sales YoY (2021-2032) & (K Units) Figure 29. Global Interleukin 1 (IL1) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Interleukin 1 (IL1) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Interleukin 1 (IL1) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Interleukin 1 (IL1) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Interleukin 1 (IL1) Revenue Market Share by Type (2021-2032) Figure 35. Global Interleukin 1 (IL1) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Interleukin 1 (IL1) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Interleukin 1 (IL1) Sales Market Share by Type (2021-2032) Figure 38. Global Interleukin 1 (IL1) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Interleukin 1 (IL1) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Interleukin 1 (IL1) Revenue Market Share by Application (2021-2032) Figure 41. Global Interleukin 1 (IL1) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Interleukin 1 (IL1) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Interleukin 1 (IL1) Sales Market Share by Application (2021-2032) Figure 44. North America Interleukin 1 (IL1) Revenue Share by Type (2021-2032) Figure 45. North America Interleukin 1 (IL1) Sales Share by Type (2021-2032) Figure 46. North America Interleukin 1 (IL1) Revenue Share by Application (2021-2032) Figure 47. North America Interleukin 1 (IL1) Sales Share by Application (2021-2032) Figure 48. North America Interleukin 1 (IL1) Revenue Share by Country (2021-2032) Figure 49. North America Interleukin 1 (IL1) Sales Share by Country (2021-2032) Figure 50. Europe Interleukin 1 (IL1) Revenue Share by Type (2021-2032) Figure 51. Europe Interleukin 1 (IL1) Sales Share by Type (2021-2032) Figure 52. Europe Interleukin 1 (IL1) Revenue Share by Application (2021-2032) Figure 53. Europe Interleukin 1 (IL1) Sales Share by Application (2021-2032) Figure 54. Europe Interleukin 1 (IL1) Revenue Share by Country (2021-2032) Figure 55. Europe Interleukin 1 (IL1) Sales Share by Country (2021-2032) Figure 56. China Interleukin 1 (IL1) Revenue Share by Type (2021-2032) Figure 57. China Interleukin 1 (IL1) Sales Share by Type (2021-2032) Figure 58. China Interleukin 1 (IL1) Revenue Share by Application (2021-2032) Figure 59. China Interleukin 1 (IL1) Sales Share by Application (2021-2032) Figure 60. Asia Interleukin 1 (IL1) Revenue Share by Type (2021-2032) Figure 61. Asia Interleukin 1 (IL1) Sales Share by Type (2021-2032) Figure 62. Asia Interleukin 1 (IL1) Revenue Share by Application (2021-2032) Figure 63. Asia Interleukin 1 (IL1) Sales Share by Application (2021-2032) Figure 64. Asia Interleukin 1 (IL1) Revenue Share by Country (2021-2032) Figure 65. Asia Interleukin 1 (IL1) Sales Share by Country (2021-2032) Figure 66. SAMEA Interleukin 1 (IL1) Revenue Share by Type (2021-2032) Figure 67. SAMEA Interleukin 1 (IL1) Sales Share by Type (2021-2032) Figure 68. SAMEA Interleukin 1 (IL1) Revenue Share by Application (2021-2032) Figure 69. SAMEA Interleukin 1 (IL1) Sales Share by Application (2021-2032) Figure 70. SAMEA Interleukin 1 (IL1) Revenue Share by Country (2021-2032) Figure 71. SAMEA Interleukin 1 (IL1) Sales Share by Country (2021-2032) Figure 72. Interleukin 1 (IL1) Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Interleukin 1 (IL1) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • APX-002
  • Diacerein CR
  • Canakinumab
  • IR-1000
  • Others
Applications
  • Fallopian Tube Cancer
  • Esophageal Cancer
  • Bechcer Disease
  • Bladder Cancer
  • Others
Companies covered
  • Novartis AG
  • AbbVie Inc
  • XBiotech Inc
  • TWi Biotechnology Inc
  • Swedish Orphan Biovitrum AB
  • Regeneron Pharmaceuticals Inc
  • R Pharm
  • Peptinov SAS
  • Orphit SAS
  • Optimum Therapeutics LLC
  • Opsona Therapeutics Ltd
  • Omnitura Therapeutics Inc
  • Immune Response BioPharma Inc
  • Exicure Inc
  • Cell Medica Ltd
  • Apexigen Inc
  • Anacor Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Interleukin 1 (IL1) Market by Type
  3. 1.2.1 Global Interleukin 1 (IL1) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 APX-002
  5. 1.2.3 Diacerein CR
  6. 1.2.4 Canakinumab
  7. 1.2.5 IR-1000
  8. 1.2.6 Others
  9. 1.3 Interleukin 1 (IL1) Market by Application
  10. 1.3.1 Global Interleukin 1 (IL1) Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Fallopian Tube Cancer
  12. 1.3.3 Esophageal Cancer
  13. 1.3.4 Bechcer Disease
  14. 1.3.5 Bladder Cancer
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Interleukin 1 (IL1) Market Dynamics
  1. 2.1 Interleukin 1 (IL1) Industry Trends
  2. 2.2 Interleukin 1 (IL1) Industry Drivers
  3. 2.3 Interleukin 1 (IL1) Industry Opportunities and Challenges
  4. 2.4 Interleukin 1 (IL1) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Interleukin 1 (IL1) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Interleukin 1 (IL1) Revenue by Region
  3. 3.2.1 Global Interleukin 1 (IL1) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Interleukin 1 (IL1) Revenue by Region (2021-2026)
  5. 3.2.3 Global Interleukin 1 (IL1) Revenue by Region (2027-2032)
  6. 3.2.4 Global Interleukin 1 (IL1) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Interleukin 1 (IL1) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Interleukin 1 (IL1) Sales by Region
  9. 3.4.1 Global Interleukin 1 (IL1) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Interleukin 1 (IL1) Sales by Region (2021-2026)
  11. 3.4.3 Global Interleukin 1 (IL1) Sales by Region (2027-2032)
  12. 3.4.4 Global Interleukin 1 (IL1) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Interleukin 1 (IL1) Revenue by Manufacturers
  2. 4.1.1 Global Interleukin 1 (IL1) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Interleukin 1 (IL1) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Interleukin 1 (IL1) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Interleukin 1 (IL1) Sales by Manufacturers
  6. 4.2.1 Global Interleukin 1 (IL1) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Interleukin 1 (IL1) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Interleukin 1 (IL1) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Interleukin 1 (IL1) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Interleukin 1 (IL1) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Interleukin 1 (IL1) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Interleukin 1 (IL1) Manufacturers, Product Type & Application
  13. 4.7 Global Interleukin 1 (IL1) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Interleukin 1 (IL1) Market CR5 and HHI
  16. 4.8.2 2025 Interleukin 1 (IL1) Tier 1, Tier 2, and Tier 3
5 Interleukin 1 (IL1) Market by Type
  1. 5.1 Global Interleukin 1 (IL1) Revenue by Type
  2. 5.1.1 Global Interleukin 1 (IL1) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Interleukin 1 (IL1) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Interleukin 1 (IL1) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Interleukin 1 (IL1) Sales by Type
  6. 5.2.1 Global Interleukin 1 (IL1) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Interleukin 1 (IL1) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Interleukin 1 (IL1) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Interleukin 1 (IL1) Price by Type
6 Interleukin 1 (IL1) Market by Application
  1. 6.1 Global Interleukin 1 (IL1) Revenue by Application
  2. 6.1.1 Global Interleukin 1 (IL1) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Interleukin 1 (IL1) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Interleukin 1 (IL1) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Interleukin 1 (IL1) Sales by Application
  6. 6.2.1 Global Interleukin 1 (IL1) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Interleukin 1 (IL1) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Interleukin 1 (IL1) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Interleukin 1 (IL1) Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Interleukin 1 (IL1) Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 AbbVie Inc
  8. 7.2.1 AbbVie Inc Company Information
  9. 7.2.2 AbbVie Inc Business Overview
  10. 7.2.3 AbbVie Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AbbVie Inc Interleukin 1 (IL1) Product Portfolio
  12. 7.2.5 AbbVie Inc Recent Developments
  13. 7.3 XBiotech Inc
  14. 7.3.1 XBiotech Inc Company Information
  15. 7.3.2 XBiotech Inc Business Overview
  16. 7.3.3 XBiotech Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 XBiotech Inc Interleukin 1 (IL1) Product Portfolio
  18. 7.3.5 XBiotech Inc Recent Developments
  19. 7.4 TWi Biotechnology Inc
  20. 7.4.1 TWi Biotechnology Inc Company Information
  21. 7.4.2 TWi Biotechnology Inc Business Overview
  22. 7.4.3 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 TWi Biotechnology Inc Interleukin 1 (IL1) Product Portfolio
  24. 7.4.5 TWi Biotechnology Inc Recent Developments
  25. 7.5 Swedish Orphan Biovitrum AB
  26. 7.5.1 Swedish Orphan Biovitrum AB Company Information
  27. 7.5.2 Swedish Orphan Biovitrum AB Business Overview
  28. 7.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Portfolio
  30. 7.5.5 Swedish Orphan Biovitrum AB Recent Developments
  31. 7.6 Regeneron Pharmaceuticals Inc
  32. 7.6.1 Regeneron Pharmaceuticals Inc Company Information
  33. 7.6.2 Regeneron Pharmaceuticals Inc Business Overview
  34. 7.6.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio
  36. 7.6.5 Regeneron Pharmaceuticals Inc Recent Developments
  37. 7.7 R Pharm
  38. 7.7.1 R Pharm Company Information
  39. 7.7.2 R Pharm Business Overview
  40. 7.7.3 R Pharm Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 R Pharm Interleukin 1 (IL1) Product Portfolio
  42. 7.7.5 R Pharm Recent Developments
  43. 7.8 Peptinov SAS
  44. 7.8.1 Peptinov SAS Company Information
  45. 7.8.2 Peptinov SAS Business Overview
  46. 7.8.3 Peptinov SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Peptinov SAS Interleukin 1 (IL1) Product Portfolio
  48. 7.8.5 Peptinov SAS Recent Developments
  49. 7.9 Orphit SAS
  50. 7.9.1 Orphit SAS Company Information
  51. 7.9.2 Orphit SAS Business Overview
  52. 7.9.3 Orphit SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Orphit SAS Interleukin 1 (IL1) Product Portfolio
  54. 7.9.5 Orphit SAS Recent Developments
  55. 7.10 Optimum Therapeutics LLC
  56. 7.10.1 Optimum Therapeutics LLC Company Information
  57. 7.10.2 Optimum Therapeutics LLC Business Overview
  58. 7.10.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Optimum Therapeutics LLC Interleukin 1 (IL1) Product Portfolio
  60. 7.10.5 Optimum Therapeutics LLC Recent Developments
  61. 7.11 Opsona Therapeutics Ltd
  62. 7.11.1 Opsona Therapeutics Ltd Company Information
  63. 7.11.2 Opsona Therapeutics Ltd Business Overview
  64. 7.11.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Portfolio
  66. 7.11.5 Opsona Therapeutics Ltd Recent Developments
  67. 7.12 Omnitura Therapeutics Inc
  68. 7.12.1 Omnitura Therapeutics Inc Company Information
  69. 7.12.2 Omnitura Therapeutics Inc Business Overview
  70. 7.12.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Portfolio
  72. 7.12.5 Omnitura Therapeutics Inc Recent Developments
  73. 7.13 Immune Response BioPharma Inc
  74. 7.13.1 Immune Response BioPharma Inc Company Information
  75. 7.13.2 Immune Response BioPharma Inc Business Overview
  76. 7.13.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Immune Response BioPharma Inc Interleukin 1 (IL1) Product Portfolio
  78. 7.13.5 Immune Response BioPharma Inc Recent Developments
  79. 7.14 Exicure Inc
  80. 7.14.1 Exicure Inc Company Information
  81. 7.14.2 Exicure Inc Business Overview
  82. 7.14.3 Exicure Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Exicure Inc Interleukin 1 (IL1) Product Portfolio
  84. 7.14.5 Exicure Inc Recent Developments
  85. 7.15 Cell Medica Ltd
  86. 7.15.1 Cell Medica Ltd Company Information
  87. 7.15.2 Cell Medica Ltd Business Overview
  88. 7.15.3 Cell Medica Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Cell Medica Ltd Interleukin 1 (IL1) Product Portfolio
  90. 7.15.5 Cell Medica Ltd Recent Developments
  91. 7.16 Apexigen Inc
  92. 7.16.1 Apexigen Inc Company Information
  93. 7.16.2 Apexigen Inc Business Overview
  94. 7.16.3 Apexigen Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Apexigen Inc Interleukin 1 (IL1) Product Portfolio
  96. 7.16.5 Apexigen Inc Recent Developments
  97. 7.17 Anacor Pharmaceuticals Inc
  98. 7.17.1 Anacor Pharmaceuticals Inc Company Information
  99. 7.17.2 Anacor Pharmaceuticals Inc Business Overview
  100. 7.17.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio
  102. 7.17.5 Anacor Pharmaceuticals Inc Recent Developments
8 North America
  1. 8.1 North America Interleukin 1 (IL1) Market Size by Type
  2. 8.1.1 North America Interleukin 1 (IL1) Revenue by Type (2021-2032)
  3. 8.1.2 North America Interleukin 1 (IL1) Sales by Type (2021-2032)
  4. 8.1.3 North America Interleukin 1 (IL1) Price by Type (2021-2032)
  5. 8.2 North America Interleukin 1 (IL1) Market Size by Application
  6. 8.2.1 North America Interleukin 1 (IL1) Revenue by Application (2021-2032)
  7. 8.2.2 North America Interleukin 1 (IL1) Sales by Application (2021-2032)
  8. 8.2.3 North America Interleukin 1 (IL1) Price by Application (2021-2032)
  9. 8.3 North America Interleukin 1 (IL1) Market Size by Country
  10. 8.3.1 North America Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Interleukin 1 (IL1) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Interleukin 1 (IL1) Market Size by Type
  2. 9.1.1 Europe Interleukin 1 (IL1) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Interleukin 1 (IL1) Sales by Type (2021-2032)
  4. 9.1.3 Europe Interleukin 1 (IL1) Price by Type (2021-2032)
  5. 9.2 Europe Interleukin 1 (IL1) Market Size by Application
  6. 9.2.1 Europe Interleukin 1 (IL1) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Interleukin 1 (IL1) Sales by Application (2021-2032)
  8. 9.2.3 Europe Interleukin 1 (IL1) Price by Application (2021-2032)
  9. 9.3 Europe Interleukin 1 (IL1) Market Size by Country
  10. 9.3.1 Europe Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Interleukin 1 (IL1) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Interleukin 1 (IL1) Market Size by Type
  2. 10.1.1 China Interleukin 1 (IL1) Revenue by Type (2021-2032)
  3. 10.1.2 China Interleukin 1 (IL1) Sales by Type (2021-2032)
  4. 10.1.3 China Interleukin 1 (IL1) Price by Type (2021-2032)
  5. 10.2 China Interleukin 1 (IL1) Market Size by Application
  6. 10.2.1 China Interleukin 1 (IL1) Revenue by Application (2021-2032)
  7. 10.2.2 China Interleukin 1 (IL1) Sales by Application (2021-2032)
  8. 10.2.3 China Interleukin 1 (IL1) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Interleukin 1 (IL1) Market Size by Type
  2. 11.1.1 Asia Interleukin 1 (IL1) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Interleukin 1 (IL1) Sales by Type (2021-2032)
  4. 11.1.3 Asia Interleukin 1 (IL1) Price by Type (2021-2032)
  5. 11.2 Asia Interleukin 1 (IL1) Market Size by Application
  6. 11.2.1 Asia Interleukin 1 (IL1) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Interleukin 1 (IL1) Sales by Application (2021-2032)
  8. 11.2.3 Asia Interleukin 1 (IL1) Price by Application (2021-2032)
  9. 11.3 Asia Interleukin 1 (IL1) Market Size by Country
  10. 11.3.1 Asia Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Interleukin 1 (IL1) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Interleukin 1 (IL1) Market Size by Type
  2. 12.1.1 SAMEA Interleukin 1 (IL1) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Interleukin 1 (IL1) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Interleukin 1 (IL1) Price by Type (2021-2032)
  5. 12.2 SAMEA Interleukin 1 (IL1) Market Size by Application
  6. 12.2.1 SAMEA Interleukin 1 (IL1) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Interleukin 1 (IL1) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Interleukin 1 (IL1) Price by Application (2021-2032)
  9. 12.3 SAMEA Interleukin 1 (IL1) Market Size by Country
  10. 12.3.1 SAMEA Interleukin 1 (IL1) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Interleukin 1 (IL1) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Interleukin 1 (IL1) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Interleukin 1 (IL1) Value Chain Analysis
  2. 13.1.1 Interleukin 1 (IL1) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Interleukin 1 (IL1) Production Mode & Process
  6. 13.2 Interleukin 1 (IL1) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Interleukin 1 (IL1) Distributors
  9. 13.2.3 Interleukin 1 (IL1) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst